Patent Assignment
Reel/Frame 067606/0247
Release of Security Interest
Recorded: 2024-06-03
Pages: 46
Assignor
OXFORD FINANCE LLC, AS COLLATERAL AGENT
Executed: 2024-05-30
Assignee
INHIBRX, INC.
11025 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA, CALIFORNIA, 92037
Covered Properties
(51)
Wap Domain Fusion Polypeptides and Methods of Use Thereof
Wap Domain Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides And Methods Of Purification Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Application:
17/315,511 →
Publication:
US 2022/0324944
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Serpin Fusion Polypeptides and Methods of Use Thereof
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Pd-1 Single Domain Antibodies and Therapeutic Compositions Thereof
Non-Immunogenic Single Domain Antibodies
Non-Immunogenic Single Domain Antibodies
Application:
16/685,087 →
Publication:
US 2020/0140525
Type Iii Secretion System Targeting Molecules
Type III Secretion System Targeting Molecules
Multivalent and Multispecific DR5-Binding Fusion Proteins
Multivalent and Multispecific DR5-Binding Fusion Proteins and Methods of Treating Neoplasms
Multivalent and Multispecific DR5-Binding Fusion Proteins and Methods of Modulating Immune Cells
Multispecific Gitr-Binding Fusion Proteins and Methods of Use Thereof
Multivalent and Multispecific Glucocorticoid-Induced Tnfr-Related Protein (Gitr)-Binding Single-Domain Antibody Fusion Proteins and Encoding Nucleic Acids
Multivalent and Multispecific OX40-Binding Fusion Proteins
Multivalent and Multispecific OX40-Binding Fusion Proteins
Multivalent and Multispecific 41BB-Binding Fusion Proteins
PDL1-Binding Proteins
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Methods of Using the Same
Multispecific Polypeptide Constructs Having Constrained CD3 Binding and Related Methods and Uses
Application:
16/380,963 →
Publication:
US 2019/0330366
B7H3 Single Domain Antibodies and Therapeutic Compositions Thereof
Application:
17/283,902 →
Publication:
US 2023/0124851
5T4 Single Domain Antibodies and Therapeutic Compositions Thereof
DLL3 Single Domain Antibodies and Therapeutic Compositions Thereof
Multispecific Polypeptide Constructs Containing a Constrained CD3 Binding Domain and a Receptor Binding Region and Methods of Using the Same
Polypeptides Comprising Modified IL-2 Polypeptides and Uses Thereof
Application:
17/418,458 →
Publication:
US 2022/0089667
OX40-Binding Polypeptides and Uses Thereof
CD123-Binding Polypeptides and Uses Thereof
CD33-Binding Polypeptides and Uses Thereof
CLEC12a Binding Polypeptides and Uses Thereof
CD123 Targeted Immunotherapies
Application:
17/608,739 →
Publication:
US 2022/0315638
CD33 Targeted Immunotherapies
Cll-1 Targeted Immunotherapies
CD8-Binding Polypeptides and Uses Thereof
Application:
63/223,786 →
CD8-Binding Polypeptides and Uses Thereof
Application:
63/288,111 →
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application:
63/223,798 →
CD8-Targeted Modified Il-2 Polypeptides and Uses Thereof
Application:
63/288,113 →
CD33 Targeted Immunotherapies
Application:
63/111,280 →
Formulations of DR5 Binding Polypeptides
Application:
63/151,131 →
NKP46-Binding Polypeptides and Uses Thereof
Application:
63/238,429 →
NKP46-Targeted Modified IL-2 Polypeptides and Uses Thereof
Application:
63/238,431 →
CD47 Antibodies and Methods of Use Thereof
CD47 Antibodies and Methods of Use Thereof
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
17/170,854 →
Publication:
US 2021/0317205
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 3, 2013
From: TIMMER, JOHN; ECKELMAN, BRENDAN; GUENTHER, GRANT B.; NGUY, PETER L.
To: INHIBRX LLC
Reel/Frame 030530/0405 →
Assignment of Assignor's Interest
Aug 30, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 031115/0609 →
Assignment of Assignor's Interest
Oct 24, 2013
From: ECKELMAN, BRENDAN; TIMMER, JOHN; DEVERAUX, QUINN
To: INHIBRX LLC
Reel/Frame 031466/0547 →
Assignment of Assignor's Interest
May 11, 2015
From: TIMMER, JOHN; ECKELMAN, BRENDAN; GUENTHER, GRANT B.; NGUY, PETER L.
To: INHIBRX LLC
Reel/Frame 035610/0562 →
Assignment of Assignor's Interest
May 11, 2015
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 035610/0709 →
Assignment of Assignor's Interest
Apr 14, 2016
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 038281/0055 →
Assignment of Assignor's Interest
Oct 20, 2016
From: TIMMER, JOHN C.; JONES, KYLE S.; RAZAI, AMIR S.; HUSSAIN, ABRAHIM
To: INHIBRX LP
Reel/Frame 040073/0748 →
Assignment of Assignor's Interest
Aug 4, 2017
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 043195/0189 →
Assignment of Assignor's Interest
Nov 15, 2017
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX LP
Reel/Frame 044133/0835 →
Change of Name
Nov 28, 2017
From: INHIBRX LLC
To: INHIBRX LP
Reel/Frame 044528/0712 →
Assignment of Assignor's Interest
Jan 24, 2018
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 044710/0285 →
Assignment of Assignor's Interest
Jan 25, 2018
From: INHIBRX LLC
To: INHIBRX LP
Reel/Frame 045150/0827 →
Assignment of Assignor's Interest
Jan 30, 2018
From: INHIBRX BIOPHARMA, LLP
To: INHIBRX LP
Reel/Frame 044762/0734 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Assignment of Assignor's Interest
Apr 30, 2019
From: ECKELMAN, BRENDAN P.; TIMMER, JOHN C.; DEVERAUX, QUINN
To: INHIBRX LP
Reel/Frame 049033/0761 →
Corrective Assignment to Correct the Nature of Conveyance Previously Recorded at Reel: 045150 Frame: 0827. Assignor(S) Hereby Confirms the Change of Name.
May 15, 2019
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 049181/0754 →
Assignment of Assignor's Interest
Mar 16, 2020
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 052121/0250 →
Assignment of Assignor's Interest
Jun 11, 2020
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 052912/0929 →
Change of Name
Oct 14, 2020
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 054074/0330 →
Assignment of Assignor's Interest
Oct 14, 2020
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 054046/0981 →
Assignment of Assignor's Interest
Oct 14, 2020
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 054046/0863 →
Assignment of Assignor's Interest
Nov 16, 2021
From: PANDIT, RAJAY A.; TIMMER, JOHN C.; SANABRIA, ANGELICA N.; SULZMAIER, FLORIAN
To: INHIBRX, INC.
Reel/Frame 058121/0619 →
Change of Name
Feb 22, 2022
From: INHIBRX LLC
To: INHIBRX, LP
Reel/Frame 059217/0264 →
Assignment of Assignor's Interest
Feb 22, 2022
From: ECKELMAN, BRENDAN; TIMMER, JOHN; NGUY, PETER L.; GUENTHER, GRANT B.
To: INHIBRX LLC
Reel/Frame 059065/0307 →
Assignment of Assignor's Interest
Feb 22, 2022
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 059065/0321 →